-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, P0Z97tiKQeR9c3r+/EVJt1iHDTAWvZKBcCAiilmDaR3MrjBhpZ+ZHPQyD08qA3y9 oWSP4mlAMadl1NsXB0cl1A== 0001094891-01-500423.txt : 20020412 0001094891-01-500423.hdr.sgml : 20020412 ACCESSION NUMBER: 0001094891-01-500423 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20011211 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LIPID SCIENCES INC/ CENTRAL INDEX KEY: 0000071478 STANDARD INDUSTRIAL CLASSIFICATION: LAND SUBDIVIDERS & DEVELOPERS (NO CEMETERIES) [6552] IRS NUMBER: 430433090 STATE OF INCORPORATION: AZ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-09142 FILM NUMBER: 1811122 BUSINESS ADDRESS: STREET 1: 7068 KOLL CENTER PARKWAY STREET 2: SUITE 401 CITY: PLEASANTON STATE: CA ZIP: 94566 BUSINESS PHONE: 925-249-4000 MAIL ADDRESS: STREET 1: 7068 KOLL CENTER PARKWAY STREET 2: SUITE 401 CITY: PLEASANTON STATE: CA ZIP: 94566 FORMER COMPANY: FORMER CONFORMED NAME: NEW MEXICO & ARIZONA LAND CO DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: NZ CORP DATE OF NAME CHANGE: 20000810 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DJORDJEVIC BOSKO CENTRAL INDEX KEY: 0001067913 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: C/O ASIA WEB HOLDINGS INC STREET 2: 1947 CAMINO VIDA ROBLE STE 102 CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 7608040023 MAIL ADDRESS: STREET 1: 1947 CAMINO VIDA ROBLE STREET 2: STE 102 CITY: CARLSBAD STATE: CA ZIP: 92008 SC 13G 1 boskodjordjevic_13g-112901.txt SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Rule 13d-102) (Amendment No. ) Lipid Sciences, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock, no par value - -------------------------------------------------------------------------------- (Title Class of Securities) 53630P101 - -------------------------------------------------------------------------------- (CUSIP Number) November 29, 2001 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |_| Rule 13d-1(b) |X| Rule 13d-1(c) |_| Rule 13d-1(d) Page 1 of 4 pages SCHEDULE 13G - -------------------------- ------------------------------- CUSIP No. 53630P101 Page 2 of 4 Pages - -------------------------- ------------------------------- - ------------------------------------------------------------------------------- 1 | NAME OF REPORTING PERSONS | S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (entities only) | | Bosko Djordjevic - ------------------------------------------------------------------------------- 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)* | (a)|_| | (b)|_| - ------------------------------------------------------------------------------- 3 | SEC USE ONLY | | - ------------------------------------------------------------------------------- 4 | SOURCE OF FUNDS*(See Instructions) | | PF- Personal Funds - ------------------------------------------------------------------------------- 5 | CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO | ITEMS 2(d) OR 2(e) |_| | - ------------------------------------------------------------------------------- 6 | CITIZENSHIP OR PLACE OF ORGANIZATION | | United States - ------------------------------------------------------------------------------- | 7 | SOLE VOTING POWER | | | | 1,502,028 NUMBER OF --------------------------------------------------- SHARES | 8 | SHARED VOTING POWER BENEFICIALLY | | OWNED BY --------------------------------------------------- EACH | 9 | SOLE DISPOSITIVE POWER REPORTING | | PERSON | | 1,502,028 WITH --------------------------------------------------- |10 | SHARED DISPOSITIVE POWER | | - ------------------------------------------------------------------------------- 11 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON | | 1,502,028 - ------------------------------------------------------------------------------- 12 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* | |_| | - ------------------------------------------------------------------------------- 13 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) | | 7.06% - ------------------------------------------------------------------------------- 14 | TYPE OF REPORTING PERSON* | | IN - ------------------------------------------------------------------------------- *SEE INSTRUCTIONS BEFORE FILLING OUT! INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEMS 1-7 (INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION. Page 2 of 4 pages Item 1. (a) Name of Issuer: Lipid Sciences, Inc. (b) Address of Issuer's Principal Executive Offices: 7068 Koll Center Parkway, Suite 401 Pleasanton, California 94566 Item 2. (a) Name of Person Filing: Bosko Djordjevic (b) Address of Principal Business Office: c/o 264 South La Cienga Blvd. Suite 215 Beverly Hills, CA 90211 (c) Citizenship: United States Citizen (d) Title of Class of Securities: Common Stock, no par value (e) CUSIP Number: 53630P101 Item 3. If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: (a) |_| Broker or dealer registered under Section 15 of the Exchange Act (b) |_| Bank as defined in Section 3(a)(6) of the Exchange Act (c) |_| Insurance company as defined in Section 3(a)(19) of the Exchange Act (d) |_| Investment company registered under Section 8 of the Investment Company Act (e) |_| An investment in accordance with Rule 13d-1(b)(1)(ii)(E) (f) |_| An employee benefit plan endowment fund, in accordance with Rule 13d-1(b)(1)(ii)(F) (g) |_| A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G) (h) |_| A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (i) |_| A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (j) |_| Group, in accordance with Rule 13d-1(b)(1)(ii)(J) Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. (a) Amount Beneficially Owned: Bosko Djordjevic beneficially owns an aggregate of 1,502,028 shares of Common Stock of Lipid Sciences, Inc. (b) Percent of Class: 7.06% (c) Number of shares as to which Bosko Djordjevic has: (i) sole power to vote or to direct vote: 1,502,028 (ii) shared power to vote or to direct vote: (iii) sole power to dispose or to direct the disposition of: 1,502,028 (iv) shared power to dispose or to direct the disposition of: Item 5. Ownership of Five Percent or Less of a Class N/A Page 3 of 4 pages Item 6. Ownership of More than Five Percent on Behalf of Another Person Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company Not applicable. Item 8. Identification and Classification of Members of the Group Not applicable. Item 9. Notice of Dissolution of Group Not applicable. Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. December 11, 2001 ------------------------------ Date /s/ Bosko Djordjevic ------------------------------- Signature Page 4 of 4 pages -----END PRIVACY-ENHANCED MESSAGE-----